by Dr. Joseph Mercola
The Aspirin U-Turn, could it also combat Cancer?
a daily low-dose of aspirin can help prevent heart attacks and strokes. Suddenly, health authorities are backpedalling on this advice. Are they trying to hide the fact it can also help with cancer,
and these
three common diseases?
Why the change?
They claim it's about bleeding risks, but there's more to the story. Look at the timing - this shift comes as newer, far more expensive blood thinners flood the market.
These drugs can cost up to $550 a month, 2 while
aspirin sets you back just $1.50. 3
The pharmaceutical industry has a long history
of this, dating back to when non-steroidal anti-inflammatory drugs (NSAIDs)
were introduced in the 1970s.
As always, I encourage you to look beyond the headlines
and consider who benefits from these changing guidelines. Your
health - and your wallet - may depend on it.
A comprehensive review of 13 primary prevention trials recently revealed that low-dose aspirin is associated with small but statistically significant reductions in major CVD events,
The absolute risk reduction can be up to 2.5%, which means that for every 1,000 people taking aspirin, up to 25 fewer may experience a major CVD event.
But the truth is, aspirin offers numerous health advantages beyond heart health that are rarely talked about.
Learning about these benefits can help you take control of your health.
Taking at least
75 milligrams (mg) of aspirin daily for several years has been shown
to reduce the long-term incidence and death from CRC, 5
with the greatest benefit seen for proximal colon cancers, which are
malignancies that occur in the first and middle sections of the
colon, also known as the right side of the colon.
The effect appears to be dose-dependent, with longer duration of use linked to greater benefits.
Aspirin may also improve survival rates after a CRC diagnosis, with regular users showing reductions in CRC mortality of 29% and overall mortality of 21%. 7
An analysis of eight trials found that the 20-year risk of any cancer death was reduced by 20%, and gastrointestinal cancer deaths by 35%.
These findings suggest that low-dose aspirin use over multiple years could be a valuable tool in your cancer prevention strategy. Research has also uncovered a role for aspirin in treating certain types of hepatocellular carcinoma (HCC), or liver cancer.
A case study revealed that aspirin effectively controlled disease progression in a patient with HCC caused by adenomatous polyposis coli (APC) mutations. 8
These mutations, which activate the Wnt pathway,
were identified as the primary driver of the patient's cancer.
The effectiveness of aspirin in this HCC case is linked to its ability to,
In
patients with APC mutations, the Wnt pathway becomes overactivated,
promoting tumor growth.
This case demonstrates how a common, inexpensive drug like aspirin could be repurposed for targeted cancer therapy based on specific genetic profiles.
A study using a mouse model found that aspirin treatment significantly improved vascular function in pregnant mice infected with influenza A virus. 10
The infected mice
showed impaired blood vessel relaxation, but aspirin treatment
restored normal vascular function.
Most notably, aspirin treatment improved outcomes for the offspring,
including better survival rates and higher birth weights.
The dosage used in the study was comparable to the low doses of aspirin already safely prescribed to some high-risk pregnant women to prevent preeclampsia. This suggests the treatment could be readily translatable to clinical use.
However, as Georgi Dinkov notes: 11
A
study presented at the 2023 meeting of the American Association for
the Study of Liver Diseases 12 revealed that low-dose
aspirin could be an effective treatment for metabolic
dysfunction-associated steatotic liver disease (MASLD), a condition
previously known as nonalcoholic fatty liver disease.
In a groundbreaking trial,
researchers found that taking 81mg of aspirin daily led to
significant improvements in liver health for patients with MASLD.
13
The study's findings are particularly exciting because they demonstrate aspirin's ability to address multiple aspects of liver health.
Not only did aspirin reduce the amount of fat in the liver,
but it also showed promise in tackling inflammation and fibrosis - two key factors in the progression of liver disease.
This
striking difference suggests that aspirin could potentially halt or
even reverse the accumulation of fat in the liver, a hallmark of MASLD.
A large-scale study involving 146,191
intensive care unit (ICU) patients found that aspirin use during ICU
stays was associated with a significant reduction in 28-day
mortality rates. 14
The findings add another layer of understanding of aspirin's many health benefits.
Not only might it help protect your liver from fat accumulation and inflammation, but it could also improve your chances of survival if you ever find yourself in intensive care.
An analysis of the ASPREE trial, which involved 16,209 adults aged 65 and older, revealed that those taking low-dose aspirin (100 mg daily) had a 15% lower risk of developing diabetes compared to those on placebo. 15
The study also found that aspirin use was associated with a slower
increase in fasting plasma glucose levels over time, revealing that
aspirin might help maintain better blood sugar control, even in
individuals who don't develop full-blown diabetes.
AAAs are a serious vascular condition that can lead to life-threatening ruptures if left unchecked.
This thickening and stiffening of the tissue
make it difficult for your lungs to work properly, leading to a
decline in lung function.
When researchers treated fibrotic lung cells with aspirin, it
markedly decreased the expression of proteins associated with
fibrosis like collagen, fibronectin, and alpha-smooth muscle actin.
Given
aspirin's wide availability, low cost and established safety
profile, it presents an intriguing option for pulmonary fibrosis
treatment.
Autophagy is your cells' way of recycling damaged components and
maintaining homeostasis. Interestingly, insufficient autophagy has
been observed in lung tissue from patients with idiopathic pulmonary
fibrosis.
When autophagy was blocked using inhibitors, it reversed aspirin's anti-fibrotic effects.
By promoting this natural cellular cleaning process, aspirin could potentially slow down or even reverse the progression of pulmonary fibrosis, adding to aspirin's diverse health benefits and opening up new possibilities for its therapeutic use.
The
analysis found that taking low-dose aspirin for more than 10 years
was critical for detecting a protective effect against dementia.
Among CHD patients, low-dose aspirin use was associated with a 31% reduced risk of Alzheimer's disease, 69% reduced risk of vascular dementia and 54% reduced risk of all-cause dementia.
If you have CHD, it's therefore possible that low-dose aspirin could provide dual benefits for your cardiovascular and cognitive health.
Therefore, you want to avoid increasing LA release from fat stores into your body.
Notably, aspirin also lowers your baseline cortisol - indirectly by reducing inflammation, and directly by inhibiting an enzyme that converts inactive cortisone to active cortisol.
Aspirin decreases
stress-induced aldosterone production, potentially helping to lower
blood pressure.
Aspirin also uncouples mitochondria.
This uncoupling of mitochondrial oxidative metabolism from ATP production can help increase your metabolic rate and aid in weight loss.
However, DNP's effective dose is dangerously close to its toxic dose, making it too risky for clinical use and no longer available in the U.S.
Check the inactive ingredients list carefully - corn starch should be the only one listed.
After thorough research,
I found a product meeting these criteria. The suggested dosage is
dependent on your circumstances 82 mg to 325 mg tablet daily with
your largest meal.
However, I use a 99% pure USP aspirin version that's not in tablet form.
If you're sensitive to aspirin, consider using a salicylic acid or willow bark supplement instead.
When you take aspirin, your body metabolizes the acetylsalicylic acid into salicylic acid, which is responsible for aspirin's anti-inflammatory, pain-relieving and antithrombotic effects.
This compound is naturally found in willow
bark.
From cancer prevention and improved pregnancy outcomes
to potential treatments for liver disease and cognitive decline,
aspirin's diverse effects warrant further research and
consideration.
The breadth of aspirin's potential benefits suggests that this common, inexpensive medication may have more to offer than "health authorities" are acknowledging in supporting overall health and preventing various chronic conditions...
Aspirin - Georgi Dinkov Clip
Sources and References
|